Abstract:The auto‐phosphorylation of murine receptor‐interacting protein 3 (Rip3) on Thr‐231 and Ser‐232 in the necrosome is required to trigger necroptosis. We identified protein phosphatase 1B (Ppm1b) as a Rip3 phosphatase and found that Ppm1brestricts necroptosis in two settings: spontaneous necroptosis caused by Rip3auto‐phosphorylation in resting cells, and tumour necrosis factor (TNF)‐α‐induced necroptosis in cultured cells. We revealed that Ppm1b selectively suppresses necroptosis through the dephosphorylation of Rip3, which then prevents the recruitment of mixed lineage kinase domain‐like protein (Mlkl) to the necrosome. We further showed that Ppm1b deficiency (Ppm1b(d/d)) in mice enhanced TNF‐‐α induced death in a Rip3‐dependent manner, and the role of Ppm1bin inhibiting necroptosis was evidenced by elevated Rip3 phosphorylation and tissue damage in the caecum of TNF‐α treated Ppm1b(d/d) mice. We also found epithelial cells in caecum damaged rapidly after TNF‐α treatment. Cecectomy could reverse TNF‐α‐induced death, but not LPS‐induced death in mice. These data indicate that Ppm1b negatively regulates necroptosis through dephosphorylating Rip3 in vitro and in vivo, and epithelial cell necroptosis in caecum may play important roles in several diseases. Support or Funding Information This work was supported by the National Basic Research Program of China (973 Program; 2015CB553800), the National Scientific and Technological Major Project (2013ZX10002‐002), the National Natural Science Foundation of China (91429301, 31420103910, 31330047, 91029304, 31221065, and 31090360), the Hi‐Tech Research and Development Program of China (863 program; 2012AA02A201), the 111 Project (B12001), the Science and Technology Foundation of Xiamen (No. 3502Z20130027), the National Science Foundation of China for Fostering Talents in Basic Research (Grant No.J1310027) and the Open Research Fund of State Key Laboratory of Cellular Stress Biology, Xiamen University. This research was also partly supported by grants from MOST (2012CB966600) and NIH (R01GM63773, R01AR053591, R01CA108454).

RIPK1 Dephosphorylation and Kinase Activation by PPP1R3G/PP1γ Promote Apoptosis and Necroptosis.

Deficiency of PPP6C protects TNF-induced necroptosis through activation of TAK1

RIP3 Induces Apoptosis Independent of Pronecrotic Kinase Activity.

Ppm1b Negatively Regulates Necroptosis Through Dephosphorylating Rip3

Diverse sequence determinants control human and mouse receptor interacting protein 3 (RIP3) and mixed lineage kinase domain-like (MLKL) interaction in necroptotic signaling.

Death-domain dimerization-mediated activation of RIPK1 controls necroptosis and RIPK1-dependent apoptosis

The RIPK1 death domain restrains ZBP1- and TRIF-mediated cell death and inflammation

Regulation of RIPK1 Phosphorylation: Implications for Inflammation, Cell Death, and Therapeutic Interventions

Tyrosine Phosphorylation Regulates RIPK1 Activity to Limit Cell Death and Inflammation.

Regulation of Ripk3-And Rhim-Dependent Necroptosis by the Proteasome

Necroptosis in health and diseases

The protein phosphatase PP6 promotes RIPK1-dependent PANoptosis

The resurrection of RIP kinase 1 as an early cell death checkpoint regulator-a potential target for therapy in the necroptosis era

Targeting RIPK3 Oligomerization Blocks Necroptosis Without Inducing Apoptosis.

Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced Inflammation

RIP1-Dependent and Independent Effects of Necrostatin-1 in Necrosis and T Cell Activation

Ppm1b Negatively Regulates Necroptosis Through Dephoshophorylating Rip3

Ubiquitination of RIPK1 Suppresses Programmed Cell Death by Regulating RIPK1 Kinase Activation During Embryogenesis.

Cutting edge: RIPK1 Kinase inactive mice are viable and protected from TNF-induced necroptosis in vivo.

RIPK3 signaling and its role in regulated cell death and diseases

Positive and Negative Phosphorylation Regulates RIP1- and RIP3-induced Programmed Necrosis